Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
Lupin
NSE: LUPIN / BSE: 500257 ~$8B MCAP
Lupin is a biopharma company.
Company Info
Recent News
Lupin Announces Approval from U.S. FDA for Pitolisant Tablets
Latest PR Newswire FDA coverage of Lupin Announces Approval from U.S. FDA for Pitolisant Tablets
Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
Lupin seeds US spinout with cash, clinical-stage cancer assets
Lupin seeds US spinout with cash, clinical-stage cancer assets.
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets Global pharmaceutical leader Lupin Limited (Lupin) (B
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets Global pharmaceutical leader Lupin Limited (Lupin) (B